Citation: Bh. Singsen et R. Goldbachmansky, METHOTREXATE IN THE TREATMENT OF JUVENILE RHEUMATOID-ARTHRITIS AND OTHER PEDIATRIC RHEUMATIC AND NONRHEUMATIC DISORDERS, Rheumatic diseases clinics of North America, 23(4), 1997, pp. 811
Citation: Ja. Fitch et Bh. Singsen, EMERGENCY AND CRITICAL CARE ISSUES IN PEDIATRIC RHEUMATOLOGY, Rheumatic diseases clinics of North America, 23(2), 1997, pp. 439
Citation: Bh. Singsen, PHYSICAL-FITNESS IN CHILDREN WITH JUVENILE RHEUMATOID-ARTHRITIS AND OTHER CHRONIC PEDIATRIC ILLNESSES, The Pediatric clinics of North America, 42(5), 1995, pp. 1035
Authors:
ROSE CD
FAWCETT PT
GIBNEY K
DOUGHTY RA
SINGSEN BH
Citation: Cd. Rose et al., SERIAL MEASUREMENTS OF SOLUBLE INTERLEUKIN-2 RECEPTOR LEVELS (SIL2-R)IN CHILDREN WITH JUVENILE RHEUMATOID-ARTHRITIS TREATED WITH ORAL METHOTREXATE, Annals of the Rheumatic Diseases, 53(7), 1994, pp. 471-474
Citation: Pg. Hunt et al., LONG-TERM (GREATER-THAN-OR-EQUAL-TO-36 MONTHS) SAFETY AND EFFICACY OFMETHOTREXATE (MTX) IN JUVENILE RHEUMATOID-ARTHRITIS (JRA), Arthritis and rheumatism, 36(9), 1993, pp. 190000061-190000061